These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 10914325)
21. Use of gelatin and gum Arabic for encapsulation of black raspberry anthocyanins by complex coacervation. Shaddel R; Hesari J; Azadmard-Damirchi S; Hamishehkar H; Fathi-Achachlouei B; Huang Q Int J Biol Macromol; 2018 Feb; 107(Pt B):1800-1810. PubMed ID: 29030181 [TBL] [Abstract][Full Text] [Related]
22. Enhancement of the in-vitro dissolution and in-vivo oral bioavailability of silymarin from liquid-filled hard gelatin capsules of semisolid dispersion using Gelucire 44/14 as a carrier. Hussein A; El-Menshawe S; Afouna M Pharmazie; 2012 Mar; 67(3):209-14. PubMed ID: 22530301 [TBL] [Abstract][Full Text] [Related]
24. Formulation development and optimization: Encapsulated system of Atenolol and Glyburide. Maboos M; Yousuf RI; Shoaib MH Pak J Pharm Sci; 2016 Mar; 29(2):569-77. PubMed ID: 27087100 [TBL] [Abstract][Full Text] [Related]
25. The effect of gelatin cross-linking on the bioequivalence of hard and soft gelatin acetaminophen capsules. Meyer MC; Straughn AB; Mhatre RM; Hussain A; Shah VP; Bottom CB; Cole ET; Lesko LL; Mallinowski H; Williams RL Pharm Res; 2000 Aug; 17(8):962-6. PubMed ID: 11028942 [TBL] [Abstract][Full Text] [Related]
26. Solid-state interaction of stearic acid with povidone and its effect on dissolution stability of capsules. Desai D; Kothari S; Huang M Int J Pharm; 2008 Apr; 354(1-2):77-81. PubMed ID: 18194844 [TBL] [Abstract][Full Text] [Related]
27. The influence of additives on the presentation of a drug in hard gelatin capsules. Newton JM; Razzo FN J Pharm Pharmacol; 1977 May; 29(5):294-7. PubMed ID: 17694 [TBL] [Abstract][Full Text] [Related]
28. Influence of capsule shell composition on the performance indicators of hypromellose capsule in comparison to hard gelatin capsules. Al-Tabakha MM; Arida AI; Fahelelbom KM; Sadek B; Saeed DA; Abu Jarad RA; Jawadi J Drug Dev Ind Pharm; 2015; 41(10):1726-37. PubMed ID: 25586554 [TBL] [Abstract][Full Text] [Related]
29. Physical stability and resistance to peroxidation of a range of liquid-fill hard gelatin capsule products on extreme long-term storage. Bowtle W; Kanyowa L; Mackenzie M; Higgins P Drug Dev Ind Pharm; 2011 Jun; 37(6):685-93. PubMed ID: 21449698 [TBL] [Abstract][Full Text] [Related]
30. Soft, chewable gelatin-based pharmaceutical oral formulations: a technical approach. Dille MJ; Hattrem MN; Draget KI Pharm Dev Technol; 2018 Jun; 23(5):504-511. PubMed ID: 28532266 [TBL] [Abstract][Full Text] [Related]
31. Preparation and characterization of novel fast disintegrating capsules (Fastcaps) for administration in the oral cavity. Ciper M; Bodmeier R Int J Pharm; 2005 Oct; 303(1-2):62-71. PubMed ID: 16111845 [TBL] [Abstract][Full Text] [Related]
32. Compatibility studies of acyclovir and lactose in physical mixtures and commercial tablets. Monajjemzadeh F; Hassanzadeh D; Valizadeh H; Siahi-Shadbad MR; Mojarrad JS; Robertson TA; Roberts MS Eur J Pharm Biopharm; 2009 Nov; 73(3):404-13. PubMed ID: 19631740 [TBL] [Abstract][Full Text] [Related]
33. Sustained-release tablets of indomethacin-loaded microcapsules: preparation, in vitro and in vivo characterization. Lu B; Wen R; Yang H; He Y Int J Pharm; 2007 Mar; 333(1-2):87-94. PubMed ID: 17081709 [TBL] [Abstract][Full Text] [Related]
34. Isothermal crystallization of Imwitor 742 from supercooled liquid state. Kawakami K Pharm Res; 2007 Apr; 24(4):738-47. PubMed ID: 17372699 [TBL] [Abstract][Full Text] [Related]
35. Development of a two-step tier-2 dissolution method for blinded overencapsulated erlotinib tablets using UV fiber optic detection. Lu X; Xiao B; Lo L; Bolgar MS; Lloyd DK J Pharm Biomed Anal; 2011 Aug; 56(1):23-9. PubMed ID: 21620602 [TBL] [Abstract][Full Text] [Related]
36. Performance qualification of a new hypromellose capsule: part I. Comparative evaluation of physical, mechanical and processability quality attributes of Vcaps Plus, Quali-V and gelatin capsules. Sherry Ku M; Li W; Dulin W; Donahue F; Cade D; Benameur H; Hutchison K Int J Pharm; 2010 Feb; 386(1-2):30-41. PubMed ID: 19900518 [TBL] [Abstract][Full Text] [Related]
37. Ketoprofen mesoporous silica nanoparticles SBA-15 hard gelatin capsules: preparation and in vitro/in vivo characterization. Abd-Elrahman AA; El Nabarawi MA; Hassan DH; Taha AA Drug Deliv; 2016 Nov; 23(9):3387-3398. PubMed ID: 27167529 [TBL] [Abstract][Full Text] [Related]
38. Determination of the physical state of drug in microcapsule and microsphere formulations. Dash AK J Microencapsul; 1997; 14(1):101-12. PubMed ID: 8994079 [TBL] [Abstract][Full Text] [Related]
39. Real time stability and viability prediction of the anticancer BCG after lyophilization. Mohamed D; Elsayed I; Mohamed AF; Yehia SA Drug Dev Ind Pharm; 2015; 41(11):1769-76. PubMed ID: 25652359 [TBL] [Abstract][Full Text] [Related]
40. Influence of histidine on the stability and physical properties of a fully human antibody in aqueous and solid forms. Chen B; Bautista R; Yu K; Zapata GA; Mulkerrin MG; Chamow SM Pharm Res; 2003 Dec; 20(12):1952-60. PubMed ID: 14725359 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]